MedPageToday
MedPage Today) — The FDA approved a label update with a new titration schedule for donanemab (Kisunla), an anti-amyloid drug approved to treat early symptomatic Alzheimer’s disease, drugmaker Eli Lilly said.
The move was designed to reduce the…
Read More
FDA Approves Label Change for Alzheimer’s Amyloid Drug
Jeanice Schewe
17:20
MedPage Today) — The FDA approved a label update with a new titration schedule for donanemab (Kisunla), an anti-amyloid drug approved to treat early symptomatic Alzheimer’s disease, drugmaker Eli Lilly said. The move was designed to reduce the…
